233 related articles for article (PubMed ID: 37258544)
1. Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation.
Pagliuca S; Gurnari C; Hercus C; Hergalant S; Hong S; Dhuyser A; D'Aveni M; Aarnink A; Rubio MT; Feugier P; Ferraro F; Carraway HE; Sobecks R; Hamilton BK; Majhail NS; Visconte V; Maciejewski JP
Nat Commun; 2023 May; 14(1):3153. PubMed ID: 37258544
[TBL] [Abstract][Full Text] [Related]
2. Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation.
Pagliuca S; Gurnari C; Hercus C; Hergalant S; Hong S; Dhuyser A; D'Aveni M; Aarnink A; Rubio MT; Feugier P; Ferraro F; Carraway HE; Sobecks R; Hamilton BK; Majhail NS; Visconte V; Maciejewski JP
Res Sq; 2023 Apr; ():. PubMed ID: 37066269
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of HLA class II is associated with relapse after allogeneic stem cell transplantation and alters recognition by antigen-specific T cells.
Adachi Y; Sakai T; Terakura S; Shiina T; Suzuki S; Hamana H; Kishi H; Sasazuki T; Arase H; Hanajiri R; Goto T; Nishida T; Murata M; Kiyoi H
Int J Hematol; 2022 Mar; 115(3):371-381. PubMed ID: 35037229
[TBL] [Abstract][Full Text] [Related]
4. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
[TBL] [Abstract][Full Text] [Related]
5. Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene.
Casucci M; Perna SK; Falcone L; Camisa B; Magnani Z; Bernardi M; Crotta A; Tresoldi C; Fleischhauer K; Ponzoni M; Gregori S; Caligaris Cappio F; Ciceri F; Bordignon C; Cignetti A; Bondanza A; Bonini C
Mol Ther; 2013 Feb; 21(2):466-75. PubMed ID: 23299798
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Patient-Specific Human Leukocyte Antigen Genomic Loss at Relapse After Antithymocyte Globulin-Based T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplant.
Wu H; Shi J; Luo Y; Yu J; Lai X; Liu L; Fu H; Ouyang G; Xu X; Xiao H; Huang H; Zhao Y
JAMA Netw Open; 2022 Apr; 5(4):e226114. PubMed ID: 35385089
[TBL] [Abstract][Full Text] [Related]
7. Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL.
Nash RA; Storb R
Curr Opin Immunol; 1996 Oct; 8(5):674-80. PubMed ID: 8902393
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation.
Rovatti PE; Gambacorta V; Lorentino F; Ciceri F; Vago L
Front Immunol; 2020; 11():147. PubMed ID: 32158444
[TBL] [Abstract][Full Text] [Related]
9. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
[TBL] [Abstract][Full Text] [Related]
10. Analysis of non-HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia.
Pearce KF; Lee SJ; Haagenson M; Petersdorf EW; Norden J; Collin MP; Klein JP; Spellman SR; Lowerson SA; Davies S; Dickinson AM
Haematologica; 2012 Jul; 97(7):1014-9. PubMed ID: 22271889
[TBL] [Abstract][Full Text] [Related]
11. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation.
Verheyden S; Schots R; Duquet W; Demanet C
Leukemia; 2005 Aug; 19(8):1446-51. PubMed ID: 15973456
[TBL] [Abstract][Full Text] [Related]
12. Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect.
Bachireddy P; Ennis C; Nguyen VN; Gohil SH; Clement K; Shukla SA; Forman J; Barkas N; Freeman S; Bavli N; Elagina L; Leshchiner I; Mohammad AW; Mathewson ND; Keskin DB; Rassenti LZ; Kipps TJ; Brown JR; Getz G; Ho VT; Gnirke A; Neuberg D; Soiffer RJ; Ritz J; Alyea EP; Kharchenko PV; Wu CJ
Sci Transl Med; 2020 Sep; 12(561):. PubMed ID: 32938797
[TBL] [Abstract][Full Text] [Related]
13. New developments in allotransplant immunology.
Barrett AJ; Rezvani K; Solomon S; Dickinson AM; Wang XN; Stark G; Cullup H; Jarvis M; Middleton PG; Chao N
Hematology Am Soc Hematol Educ Program; 2003; ():350-71. PubMed ID: 14633790
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell transplantation and cellular therapy.
Kolb HJ
HLA; 2017 May; 89(5):267-277. PubMed ID: 28371460
[TBL] [Abstract][Full Text] [Related]
15. Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease.
Chang YJ; Zhao XY; Huang XJ
Front Immunol; 2018; 9():3041. PubMed ID: 30619371
[TBL] [Abstract][Full Text] [Related]
16. Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
Daull AM; Dubois V; Labussière-Wallet H; Venet F; Barraco F; Ducastelle-Lepretre S; Larcher MV; Balsat M; Gilis L; Fossard G; Ghesquières H; Heiblig M; Ader F; Alcazer V
Front Immunol; 2022; 13():841470. PubMed ID: 35309346
[TBL] [Abstract][Full Text] [Related]
17. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
Michallet M; Dhedin N; Michallet AS
Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
[TBL] [Abstract][Full Text] [Related]
18. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.
Weisdorf DJ; Nelson G; Lee SJ; Haagenson M; Spellman S; Antin JH; Bolwell B; Cahn JY; Cervantes F; Copelan E; Gale R; Gratwohl A; Khoury HJ; McCarthy P; Marks DI; Szer J; Woolfrey A; Cortes-Franco J; Horowitz MM; Arora M;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1475-8. PubMed ID: 19822308
[TBL] [Abstract][Full Text] [Related]
19. Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia.
Stevanović S; Nijmeijer BA; van Schie ML; Salvatori DC; Maas S; Griffioen M; Falkenburg JH
Biol Blood Marrow Transplant; 2013 Jun; 19(6):867-75. PubMed ID: 23500532
[TBL] [Abstract][Full Text] [Related]
20. Loss of mismatched HLA in acute myeloid leukemia relapse after haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood: A case report.
Han X; Zhao J; Liu J; Guo D; Li H; Fan S
Transpl Immunol; 2022 Aug; 73():101602. PubMed ID: 35429620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
